Retinal replacement--the development of microelectronic retinal prostheses--experience with subretinal implants and new aspects.

Graefes Arch Clin Exp Ophthalmol

University Eye Clinic, University of Regensburg, Franz Josef Strauss Allee 11, 93042 Regensburg, Germany.

Published: August 2004

Background: Progress in the field of microelectronics has led to the development of visual prostheses for the treatment of blinding diseases. Different concepts of retinal replacement are currently under investigation. The aim of the retinal prostheses is to replace the function of lost photoreceptors in degenerative diseases, such as retinitis pigmentosa.

Methods: Within the field of visual prosthetic developments mainly two retinal based concepts are under investigation. One of the concepts is the epiretinal implant which acquires images of an external camera and after preprocessing by a computer reading this visual information into the human visual system. In the subretinal prosthesis design concept an array of stimulation electrodes is placed in the subretinal space. True to the concept the image falling on the retina and its light impulses are converted into electrical currents by microphotodiodes and the retina is stimulated with these locally. To test the feasibility of the concepts the biocompatibility and to determine basic stimulation parameters a lot of animal experiments and first human experiments were carried out.

Results: Currently the research conducted by teams in Germany, the USA and Japan into epiretinal and subretinal implants has reached the stage where clinical trials can now be performed. Individual pilot studies were carried out for both the epiretinal and the subretinal implant by different research groups.

Discussion: The results achieved by the researchers indicate that cortical action potentials can be triggered by electric retinal stimulation with both concepts. The experimental work has highlighted a whole range of obstacles, not all of which have yet been fully resolved. These findings offer hope that coarse restoration of vision may be feasible by electrical stimulation.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00417-004-0979-7DOI Listing

Publication Analysis

Top Keywords

subretinal implants
8
epiretinal subretinal
8
retinal
6
subretinal
5
concepts
5
retinal replacement--the
4
replacement--the development
4
development microelectronic
4
microelectronic retinal
4
retinal prostheses--experience
4

Similar Publications

Intraoperative optical coherence tomography (iOCT) has been applied and studied in a variety of vitreoretinal surgeries for its feasibility, safety, and outcomes for years. Common scenarios include membrane peeling procedures, retinal detachments, choroidal-retinal biopsies, Argus implants, and subretinal injections. iOCT offers the surgeon a better understanding of the retinal microarchitectural changes and timely intraoperative feedback, directing a future view of precision surgery.

View Article and Find Full Text PDF

Clinical and Histopathologic Findings in Jalili Syndrome.

Ophthalmol Retina

November 2024

Ophthalmology Unit, Unidade Local de Saúde (ULS) Coimbra, Coimbra, Portugal; Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal; Faculty of Medicine, University of Coimbra, Coimbra, Portugal; University of Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, Coimbra, Portugal; University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Coimbra, Portugal. Electronic address:

Purpose: To correlate histopathologic findings in an eye with Jalili syndrome with clinical and imaging results available before enucleation.

Design: Case report with histopathologic analysis.

Subjects: Histopathologic analysis of an enucleated eye from a 63-year-old woman diagnosed with Jalili syndrome.

View Article and Find Full Text PDF

Purpose: The current standard of care for neovascular age-related macular degeneration is serial vascular endothelial growth factor (VEGF) inhibitor intravitreal injections at varying treatment intervals. SUSVIMO is a port-delivery system of ranibizumab that serves as an alternative, lower-maintenance treatment.

Methods: A case report from a retinal surgery clinic describing the ocular findings, diagnostic workup, and alternative treatment for an 80-year-old man presenting with new-onset neovascular age-related macular degeneration.

View Article and Find Full Text PDF

Purpose: To outline the therapeutic approach for a rare case of Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP) and examine the current management recommendations of this uncommon condition.

Methods-results: Literature review on the current treatment options in BDUMP cases. An 82-year-old woman was referred to our clinic due to bilateral visual loss.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the safety and effectiveness of dexamethasone implants for treating macular edema (ME) caused by acute retinal necrosis (ARN) in five patients.
  • Results showed that all patients experienced significant relief from ME after the treatment, with no reported recurrences of retinal necrosis or side effects like increased eye pressure.
  • The findings suggest that intravitreal dexamethasone injections can improve visual acuity and effectively manage ME associated with ARN without causing adverse reactions.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!